Repligen(RGEN.US)

Event Tracking

Dec18

Repligen Director Karen Sells Company Stock

21:33

Dec16

JP Morgan Analyst Reiterates Buy Rating on Repligen

15:12

Repligen Launches New Chromatography Resins to Enhance Gene Therapy Workflow

12:52

Nov26

Repligen CEO Disposes of Common Stock

21:31

Lisa C. McClain sold Repligen Corporation stock

19:16

Blue Whale Capital Acquired Repligen Corporation Stock in Q2

08:31

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 188.81 M, Net Income 14.91 M, EPS 0.26

Jul29

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 182.37 M, Net Income 14.87 M, EPS 0.26

Apr29

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 169.17 M, Net Income 5.83 M, EPS 0.1

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change